Loading [MathJax]/jax/output/SVG/jax.js
Mini review Topical Sections

The brain-gut axis: communication mechanisms and the role of the microbiome as a neuroprotective factor in the development of neurodegenerative diseases: A literature overview

  • The study of the brain-gut axis and its impact on cognitive function and in the development of neurodegenerative diseases is a very timely topic of interest to researchers. This review summarizes information on the basic mechanisms of gut-brain communication. We then discuss the roles of the gut microbiome as a neuroprotective factor in neurodegeneration. The gut microbiota is extremely important in maintaining the body's homeostasis, shaping the human immune system and the proper functioning of the brain. The intestinal microflora affects the processes of neuroplasticity, synaptogenesis, and neuronal regeneration. This review aims to explain changes in the composition of the bacterial population of the intestinal microflora among patients with Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Abnormalities in gut microflora composition are also noted in stress, depression, or autism spectrum development. New observations on psychobiotic supplementation in alleviating the symptoms of neurodegenerative diseases are also presented.

    Citation: mgr Natalia Białoń, dr hab. n. o zdr. Dariusz Górka, mgr Mikołaj Górka. The brain-gut axis: communication mechanisms and the role of the microbiome as a neuroprotective factor in the development of neurodegenerative diseases: A literature overview[J]. AIMS Neuroscience, 2024, 11(3): 289-311. doi: 10.3934/Neuroscience.2024019

    Related Papers:

    [1] Jing Huang, Qian Wang, Rui Zhang . On a binary Diophantine inequality involving prime numbers. AIMS Mathematics, 2024, 9(4): 8371-8385. doi: 10.3934/math.2024407
    [2] Jing Huang, Ao Han, Huafeng Liu . On a Diophantine equation with prime variables. AIMS Mathematics, 2021, 6(9): 9602-9618. doi: 10.3934/math.2021559
    [3] Bingzhou Chen, Jiagui Luo . On the Diophantine equations $x^2-Dy^2=-1$ and $x^2-Dy^2=4$. AIMS Mathematics, 2019, 4(4): 1170-1180. doi: 10.3934/math.2019.4.1170
    [4] Jing Huang, Wenguang Zhai, Deyu Zhang . On a Diophantine equation with four prime variables. AIMS Mathematics, 2025, 10(6): 14488-14501. doi: 10.3934/math.2025652
    [5] Hunar Sherzad Taher, Saroj Kumar Dash . Repdigits base $ \eta $ as sum or product of Perrin and Padovan numbers. AIMS Mathematics, 2024, 9(8): 20173-20192. doi: 10.3934/math.2024983
    [6] Liuying Wu . On a Diophantine equation involving fractional powers with primes of special types. AIMS Mathematics, 2024, 9(6): 16486-16505. doi: 10.3934/math.2024799
    [7] Ashraf Al-Quran . T-spherical linear Diophantine fuzzy aggregation operators for multiple attribute decision-making. AIMS Mathematics, 2023, 8(5): 12257-12286. doi: 10.3934/math.2023618
    [8] Cheng Feng, Jiagui Luo . On the exponential Diophantine equation $ \left(\frac{q^{2l}-p^{2k}}{2}n\right)^x+(p^kq^ln)^y = \left(\frac{q^{2l}+p^{2k}}{2}n\right)^z $. AIMS Mathematics, 2022, 7(5): 8609-8621. doi: 10.3934/math.2022481
    [9] Jinyan He, Jiagui Luo, Shuanglin Fei . On the exponential Diophantine equation $ (a(a-l)m^{2}+1)^{x}+(alm^{2}-1)^{y} = (am)^{z} $. AIMS Mathematics, 2022, 7(4): 7187-7198. doi: 10.3934/math.2022401
    [10] Sohail Ahmad, Ponam Basharat, Saleem Abdullah, Thongchai Botmart, Anuwat Jirawattanapanit . MABAC under non-linear diophantine fuzzy numbers: A new approach for emergency decision support systems. AIMS Mathematics, 2022, 7(10): 17699-17736. doi: 10.3934/math.2022975
  • The study of the brain-gut axis and its impact on cognitive function and in the development of neurodegenerative diseases is a very timely topic of interest to researchers. This review summarizes information on the basic mechanisms of gut-brain communication. We then discuss the roles of the gut microbiome as a neuroprotective factor in neurodegeneration. The gut microbiota is extremely important in maintaining the body's homeostasis, shaping the human immune system and the proper functioning of the brain. The intestinal microflora affects the processes of neuroplasticity, synaptogenesis, and neuronal regeneration. This review aims to explain changes in the composition of the bacterial population of the intestinal microflora among patients with Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Abnormalities in gut microflora composition are also noted in stress, depression, or autism spectrum development. New observations on psychobiotic supplementation in alleviating the symptoms of neurodegenerative diseases are also presented.



    In many areas of the objective world, such as target tracking, machine learning system identification, associative memories, pattern recognition, solving optimization problems, image processing, signal processing, and so on [1,2,3,4,5], a lot of practical problems can be described by delay differential equations (DDEs). Therefore, the research of delay differential equations has been the subject of significant attention [6,7]. As we all know, time delays are inevitable in population dynamics models. For example, the maturation period should be considered in the study of simulated biological species [8,9], incubation periods should be considered in epidemiology area [7], and the synaptic transmission time among neurons should be considered in neuroscience field [10]. In particular, the dynamic behavior of most cellular neural network models is significantly affected by time delay, so the investigation on delayed cellular neural networks has been the world-wide focus.

    It should be mentioned that proportional delay is one of important time-varying delays, which is unbounded and monotonically increasing, and is more predictable and controllable than constant delay and bounded time-varying delay. Over past decade, by introducing proportional time delay, investigations of the following neutral type proportional delayed cellular neural networks (CNNs) with D operators:

    [xi(t)pi(t)xi(rit)]=ai(t)xi(t)+nj=1eij(t)fj(xj(t))+nj=1bij(t)gj(xj(qijt))+Ii(t),tt0>0, iN={1,2,,n}, (1.1)

    with initial value conditions:

    xi(s)=φi(s), s[ρit0, t0], φiC([ρit0, t0],R), ρi=min{ri,min1jn{qij}}, iN, (1.2)

    have attracted great attention of some researchers. The main reason is that its successful applications in variety of areas such as optimization, associative memories, signal processing, automatic control engineering and so on (see [11,12,13,14,15] and the references therein). Here n is the number of units in a neural network, (x1(t),x2(t),,xn(t))T corresponds to the state vector, the decay rate at time t is designated by ai(t), coefficients pi(t), eij(t) and bij(t) are the connection weights at the time t, fj and gj are the activation functions of signal transmission, ri(t)0 denotes the transmission delay, ri and qij are proportional delay factors and satisfy 0<ri, qij<1, Ii(t) is outside input.

    As pointed out by the authors of reference [16], the weighted pseudo almost periodic function consists of an almost periodic process plus a weighted ergodic component. It is well known that the weighted pseudo-almost periodic phenomenon is more common in the environment than the periodic, almost periodic and pseudo-almost periodic phenomenon, so the dynamic analysis of the weighted pseudo-almost periodic is more realistic [17,18,19,20]. Furthermore, when pi(t)0, the existence and exponential stability of weighted pseudo almost periodic solutions (WPAPS) of proportional delayed cellular neural networks (CNNs)

    xi(t)=ai(t)xi(t)+nj=1eij(t)fj(xj(t))+nj=1bij(t)gj(xj(qijt))+Ii(t), tt0>0, iN, (1.3)

    have been established in [22] under the following conditions

    suptR{˜ai(t)+Ki[ξ1inj=1(|eij(t)|Lfj+|bij(t)|Lgj)ξj]}<γi. (1.4)

    {Here, for iN, ˜aiC(R, (0, +)) is a bounded function, and Ki>0 is a constant with

    etsai(u)duKiets˜ai(u)du   for all  t,sR  and  ts0.

    In addition, fj and gj are the activation functions with Lipschitz constants Lfj and Lgj obeying

    |fj(u)fj(v)|Lfj|uv|,  |gj(u)gj(v)|Lgj|uv|   for all u,vR, iN.

    } It should be mentioned that the authors in [22] use (1.4) to show that there exists a constant λ(0,miniN˜ai) such that

    Πi(λ)=suptR{λ˜ai(t)+Ki[ξ1inj=1(|eij(t)|Lfj+|bij(t)|Lgjeλ(1qij)t)ξj]}<0, iN. (1.5)

    With the aid of the fact that limt+eλ(1qij)t=+, it is easy to see that (1.4) can not lead to (1.5). Meanwhile, Examples 4.1 and 4.2 in [22] also have the same error, where

    bij(t)=110(i+j)sin2t, i,j=1,2,

    and

    b1j(t)=1100(cos(1+j)t),b2j(t)=1100(cos(1+j)t+cos2t),b3j(t)=1100(cos(1+j)t+sin2t),}j=1,2,3,

    can not also meet (1.5). For detail, the biological explanations on equations (1.4) and (1.5) can be found in [22]. Now, in order to improve [22], we will further study the existence and exponential stability of weighted pseudo almost periodic solutions for (1.1) which includes (1.3) as a special case. Moreover, this class of models has not been touched in the existing literature.

    On account of the above considerations, in this article, we are to handle the existence and generalized exponential stability of weighted pseudo almost periodic solutions for system (1.1). Readers can find the following Remark 2.1 for extensive information. In a nutshell, the contributions of this paper can be summarized as follows. 1) A class of weighted pseudo almost periodic cellular neural network model with neutral proportional delay is proposed; 2) Our findings not only correct the errors in [22], but also improve and complement the existing conclusions in the recent publications [22,23]; 3) Numerical simulations including comparison analyses are presented to verify the obtained theoretical results.

    The remainder of the paper is organized as follows. We present the basic notations and assumptions in Section 2. The existence and exponential stability of weighted pseudo almost periodic solutions for the addressed neural networks models are proposed in Section 3. The validity of the proposed method is demonstrated in Section 4, and conclusions are drawn in Section 5.

    Notations. R and Rn denote the set of real numbers and the n-dimensional real spaces. For any x={xij}Rmn, let |x| denote the absolute value vector given by |x|={|xij|}, and define x=maxijJ|xij(t)|. Given a bounded continuous function h defined on R, let h+=suptR|h(t)|, h=inftR|h(t)|. We define U be the collection of functions (weights) μ:R(0,+) satisfying

    U:={μ | μU,infxRμ(x)=μ0>0},

    and

    U+:={μ|μU,lim sup|x|+μ(αx)μ(x)<+,lim supr+μ([αr, αr])μ([r, r])<+, α(0,+)}.

    Let BC(R,Rn) denote the collection of bounded and continuous functions from R to Rn. Then (BC(R,Rn),) is a Banach space, where f:=suptRf(t). Also, this set of the almost periodic functions from R to Rn will be designated by AP(R,Rn). Furthermore, the class of functions PAPμ0(R,Rn) be defined as

    PAPμ0(R,Rn)={φBC(R,Rn)|limr+1μ([r, r])rrμ(t)|φ(t)|dt=0}.

    A function fBC(R,Rn) is said to be weighted pseudo almost periodic if there exist hAP(R,Rn) and φPAPμ0(R,Rn) satisfying

    f=h+φ,

    where h and φ are called the almost periodic component and the weighted ergodic perturbation of weighted pseudo almost periodic function f, respectively. We designate the collection of such functions by PAPμ(R,Rn). In addition, fixed μU+, (PAPμ(R,Rn),.) is a Banach space and AP(R,Rn) is a proper subspace of PAPμ(R,Rn). For more details about the above definitions can be available from [17,18] and the references cited therein.

    In what follows, for i,jN, we shall always assume that  eij,bij,pi,IiPAPμ(R,R), and

    aiAP(R,R),  M[ai]=limT+1Tt+Ttai(s)ds>0. (2.1)

    For i,jN, we also make the following technical assumptions:

    (H1) there are a positive function ˜aiBC(R,R) and a constant Ki>0 satisfying

    etsai(u)duKiets˜ai(u)du   for all t,sR  and  ts0.

    (H2) there exist nonnegative constants Lfj and Lgj such that

    |fj(u)fj(v)|Lfj|uv|,|gj(u)gj(v)|Lgj|uv|   for all u,vR.

    (H3) μU+, we can find constants ξi>0 and Λi>0 such that

    suptR1˜ai(t)Ki[|ai(t)pi(t)|+ξ1inj=1(|eij(t)|Lfj+|bij(t)|Lgj)ξj]<Λi,
    suptt0{˜ai(t)+Ki[|ai(t)pi(t)|11p+i+ξ1inj=1|eij(t)|Lfjξj11p+j+ξ1inj=1|bij(t)|Lgjξj11p+j]}<0,

    and

    p+i+Λi<1, iN.

    Remark 2.1. From (H1) and (H2), one can use an argument similar to that applied in Lemma 2.1 of [24] to demonstrate that every solution of initial value problem (1.1) and (1.2) is unique and exists on [t0, +).

    In this section, we will establish some results about the global generalized exponential stability of the weighted pseudo almost periodic solutions of (1.1). To do this end, we first show the following Lemma.

    Lemma 3.1. (see[[22], Lemma 2.1]). Assume that fPAPμ(R,R) and βR{0}. Then, f(βt)PAPμ(R,R).

    Using a similar way to that in lemma 2.3 of [22], we can show the following lemma:

    Lemma 3.2. Assume that (H1) and (H2) hold. Then, the nonlinear operator G:

    (Gφ)i(t)=tetsai(u)du[ai(s)pi(s)φi(ris)+ξ1inj=1eij(s)fj(ξjφj(s))+ξ1inj=1bij(s)gj(ξjφj(qijs))+ξ1iIi(s)]ds, iN, φPAPμ(R,Rn),

    maps PAPμ(R,Rn) into itself.

    Theorem 3.1. Suppose that (H1), (H2) and (H3) are satisfied. Then, system (1.1) has exactly one WPAPS x(t)PAPμ(R,Rn), which is globally generalized exponentially stable, that is, for every solution x(t) agreeing with (1.1)(1.2), there exists a constant σ(0,miniN˜ai) such that

    xi(t)xi(t)=O((11+t)σ)  as t+   for all iN.

    Proof. With the help of (H3), it is easy to see that there are constants σ,λ(0, miniN˜ai) such that

    p+ieσln1ri<1, suptReλ˜ai(t)Ki[|ai(t)pi(t)|+ξ1inj=1(|eij(t)|Lfj+|bij(t)|Lgj)ξj]<Λi, iN, (3.1)

    and

    suptt0{σ˜ai(t)+Ki[|ai(t)pi(t)|11p+ieσln1rieσln1ri+ξ1inj=1|eij(t)|Lfjξj11p+jeσln1rj+ξ1inj=1|bij(t)|Lgjξj11p+jeσln1rjeσln(1qij)]}<0, iN, (3.2)

    which, along with the inequalities

    σ1+tσ, ln(1+t1+rit)ln1ri, ln(1+t1+qijt)ln1qij  for all t0, i,jN,

    yield

    suptt0{σ1+t˜ai(t)+Ki[|ai(t)pi(t)|11p+ieσln1rieσln1+s1+rit+ξ1inj=1|eij(t)|Lfjξj11p+jeσln1rj+ξ1inj=1|bij(t)|Lgjξj11p+jeσln1rjeσln(1+t1+qijt)]}suptt0{σ˜ai(t)+Ki[|ai(t)pi(t)|11p+ieσln1rieσln1ri+ξ1inj=1|eij(t)|Lfjξj11p+jeσln1rj+ξ1inj=1|bij(t)|Lgjξj11p+jeσln1rjeσln(1qij)]}<0, iN. (3.3)

    Consequently, applying a transformation:

    yi(t)=ξ1ixi(t), Yi(t)=yi(t)pi(t)yi(rit), iN,

    leads to

    Yi(t)=ai(t)Yi(t)ai(t)pi(t)yi(rit)+ξ1inj=1eij(t)fj(ξjyj(t))+ξ1inj=1bij(t)gj(ξjyj(qijt))+ξ1iIi(t), iN. (3.4)

    Now, define a mapping P:PAPμ(R,Rn)PAPμ(R,Rn) by setting

    (Pφ)i(t)=pi(t)φi(rit)+(Gφ)i(t)   for all iN, φPAPμ(R,Rn), (3.5)

    it follows from Lemma 3.1 and Lemma 3.2 that PφPAPμ(R,Rn).

    Moreover, by means of (H1), (H2) and (H3), for φ,ψPAPμ(R,Rn), we have

    |(Pφ)i(t)(Pψ)i(t)|=|pi(t)[φi(rit)ψi(rit)]+tetsai(u)du[ξ1inj=1eij(s)(fj(ξjφj(s))fj(ξjψj(s)))+ξ1inj=1bij(s)(gj(ξjφj(qijs))gj(ξjψj(qijs)))]ds|{p+i+tets˜ai(u)duKi[ξ1inj=1(|eij(s)|Lfj+|bij(s)|Lgj)ξj]ds}φ(t)ψ(t){pi+Λitets˜ai(u)du1eλ˜ai(s)ds}φ(t)ψ(t){pi+Λi1eλ}φ(t)ψ(t),

    which and the fact that 0<maxiN{p+i+Λi}<1 suggest that the contraction mapping P possesses a unique fixed point

    y={yi(t)}PAPμ(R,Rn), Py=y.

    Thus, (1.5) and (3.5) entail that x={xi(t)}={ξiyi(t)}PAPμ(R,Rn) is a weighted pseudo almost periodic solution of (1.1).

    Finally, we demonstrate that x is exponentially stable.

    Designate x(t)={xi(t)} be an arbitrary solution of (1.1) with initial value φ(t)={φi(t)} satisfying (1.2).

    Label

    xi(t)=φi(t)=φi(σit0), for all  t[riσit0, σit0],  (3.6)
    yi(t)=ξ1ixi(t), yi(t)=ξ1ixi(t),zi(t)=yi(t)yi(t)),Zi(t)=zi(t)pi(t)zi(rit), iN.

    Then

    Zi(t)=ai(t)Zi(t)ai(t)pi(t)zi(rit)+ξ1inj=1eij(t)(fj(ξjyj(t))fj(ξjyj(t)))+ξ1inj=1bij(t)(gj(ξjyj(qijt))gj(ξjyj(qijt))), iN. (3.7)

    Without loss of generality, let

    φxξ=maxiN{supt[ρit0,t0]ξ1i|[φi(t)pi(t)φi(rit)][xi(t)pi(t)xi(rit)]|}>0, (3.8)

    and M be a constant such that

    M>Ni=1Ki+1. (3.9)

    Consequently, for any ε>0, it is obvious that

    |Zi(t)|<M(φxξ+ε)eσln1+t1+t0  for all  t(ρit0, t0], iN. (3.10)

    Now, we validate that

    Z(t)<M(φxξ+ε)eσln1+t1+t0  for all  t>t0. (3.11)

    Otherwise, there must exist iN and θ>t0 such that

    {|Zi(θ)|=M(φxξ+ε)eσln1+θ1+t0,   Z(t)<M(φxξ+ε)eσln1+t1+t0  for all  t(ρit0, θ). (3.12)

    Furthermore, from (3.6), we obtain

    eσln1+ν1+t0|zj(ν)|eσln1+ν1+t0|zj(ν)pj(ν)zj(rjν)|+eσln1+ν1+t0|pj(ν)zj(rjν)|eσln1+ν1+t0|Zj(ν)|+p+jeσln1+ν1+rjνeσln1+rjν1+t0|zj(rjν)|M(φxξ+ε)+p+jeσln1rjsups[rjρjt0, rjt]eσln1+s1+t0|zj(s)|M(φxξ+ε)+p+jeσln1rjsups[ρit0, t]eσln1+s1+t0|zj(s)|, (3.13)

    for all  ν[ρjt0, t], t[t0, θ), jJ, which entails that

    eσln1+t1+t0|zj(t)|sups[ρjt0, t]eσln1+s1+t0|zj(s)|M(φxξ+ε)1p+jeσln1rj,  (3.14)

    for all t[ρit0, θ), jN.

    Note that

    Zi(s)+ai(s)Zi(s)=ai(s)pi(s)zi(ris)+ξ1inj=1eij(s)(fj(ξjyj(s))fj(ξjyj(s)))+ξ1inj=1bij(s)(gj(ξjyj(qijs))gj(ξjyj(qijs))),  s[t0,t], t[t0,θ]. (3.15)

    Multiplying both sides of (3.15) by est0ai(u)du, and integrating it on [t0,t], we get

    Zi(t)=Zi(t0)ett0ai(u)du+tt0etsai(u)du[ai(s)pi(s)zi(ris)+ξ1inj=1eij(s)(fj(ξjyj(s))fj(ξjyj(s)))+ξ1inj=1bij(s)(gj(ξjyj(qijs))gj(ξjyj(qijs)))]ds, t[t0,θ].

    Thus, with the help of (3.3), (3.9), (3.12) and (3.14), we have

    |Zi(θ)|=|Zi(t0)eθt0ai(u)du+θt0eθsai(u)du[ai(s)pi(s)zi(ris)+ξ1inj=1eij(s)(fj(ξjyj(s))fj(ξjyj(s)))+ξ1inj=1bij(s)(gj(ξjyj(qijs))gj(ξjyj(qijs)))]ds|(φxξ+ε)Kieθt0˜ai(u)du+θt0eθs˜ai(u)duKi[|ai(s)pi(s)zi(ris)|+ξ1inj=1|eij(s)|Lfjξj|zj(s)|+ξ1inj=1|bij(s)|Lgjξj|zj(qijs)|]ds(φxξ+ε)Kieθt0˜ai(u)du+θt0eθs˜ai(u)duKi[|ai(s)pi(s)|M(φxξ+ε)1p+ieσln1rieσln1+ris1+t0+ξ1inj=1|eij(s)|LfjξjM(φxξ+ε)1p+jeσln1rjeσln1+s1+t0+ξ1inj=1|bij(s)|LgjξjM(φxξ+ε)1p+jeσln1rjeσln1+qijs1+t0]ds=M(φxξ+ε)eσln1+θ1+t0{KiMeθt0[˜ai(u)σ1+u]du+θt0eθs[˜ai(u)σ1+u]duKi[|ai(s)pi(s)|11p+ieσln1rieσln1+s1+ris+ξ1inj=1|eij(s)|Lfjξj11p+jeσln1rj+ξ1inj=1|bij(s)|Lgjξj11p+jeσln1rjeσln(1+s1+qijs)]ds}M(φxξ+ε)eσln1+θ1+t0{KiMeθt0[˜ai(u)σ1+u]du+θt0eθs[˜ai(u)σ1+u]duKi[|ai(s)pi(s)|11p+ieσln1rieσln1ri+ξ1inj=1|eij(s)|Lfjξj11p+jeσln1rj+ξ1inj=1|bij(s)|Lgjξj11p+jeσln1rjeσln(1qij)]ds}M(φxξ+ε)eσln1+θ1+t0[1(1KiM)eθt0(˜ai(u)σ1+u)du]<M(φxξ+ε)eσln1+θ1+t0.

    This is a clear contradiction of (3.12). Hence, (3.11) holds. When ε0+, we obtained

    Z(t)Mφxξeσln1+θ1+t0     for all  t>t0. (3.17)

    Then, using a similar derivation in the proof of (3.13) and (3.14), with the help of (3.17), we can know that

    eσln1+t1+t0|zj(t)|sups[ρjt0, t]eσln1+s1+t0|zj(s)|Mφxξ1p+jeσln1rj,

    and

    |zj(t)|Mφxξ1p+jeσln1rj(1+t01+t)σ     for all  t>t0, jN.

    The proof of the Theorem 3.1 is now finished.

    Theorem 3.2. Let μU+. Assume that (H1) and (H2) hold, and there exist constants γi,ξi>0 such that

    suptR{˜ai(t)+Ki[ξ1inj=1(|eij(t)|Lfj+|bij(t)|Lgj)ξj]}<γi   for all  iN, (3.18)

    holds. Then, system (1.3) has a unique WPAPS x(t)PAPμ(R,Rn), and there is a constant σ(0,miniN˜ai) such that

    xi(t)xi(t)=O((11+t)σ)  as t+, 

    here iN, x(t) is an arbitrary solution of system (1.3) with initial conditions:

    xi(s)=φi(s), s[ρit0, t0], φiC([ρit0, t0],R), ρi=min1jn{qij}, iN.

    Proof. From (3.18) we can pick a positive constant Λi such that

    suptR1˜ai(t)Ki[ξ1inj=1(|eij(t)|Lfj+|bij(t)|Lgj)ξj]<Λi<1, iN. (3.19)

    According to fact that (1.3) is a special case of (1.1) with p+i=0 (iN), the proof proceeds in the same way as in Theorem 3.1.

    Remark 3.1. Obviously, it is easy to see that all results in [22] are the special case of Theorem 2.2 in this manuscript. In particular, the wrong in (1.5) has been successfully corrected. This indicates that our results supplement and improve the previous references [22,23]

    In order to reveal the correctness and feasibility of the obtained results, an example with the simulation is introduced in this section.

    Example 4.1. Consider the following CNNs with D operator and multi-proportional delays:

    {[x1(t)sint100x1(13t)]=(15+310sin20t)x1(t)+120(sin2t+et2(sint)2)120arctan(x1(t))+120(sin3t+et4(sint)4)120arctan(x2(t))+120(cos2t+et2(cost)2)120x1(12t)+120(cos3t+et4(cost)4)120x2(13t)+et2+sin(3t),[x2(t)cost100x2(13t)]=(15+310cos20t)x2(t)+120(cos2t+et2(cost)2)120arctan(x1(t))+120(cos3t+et4(cost)4)120arctan(x2(t))+120(cos3t+et6(cost)6)120x1(13t)+120(cos5t+et8(cost)8)120x2(14t)+et4+sin(5t). (4.1)

    Clearly,

    n=2, qij=1i+j, t0=1, fi(x)=120arctanx, gi(x)=120x, i,j=1,2.

    Then, we can take

    ˜ai(t)=15, ξi=1, Lfi=Lgi=120, Ki=e310, μ(t)=t2+1, i,j=1,2,

    such that CNNs (1.1) with (4.1) satisfies all the conditions (H1)(H3). By Theorem 2.1, we can conclude that CNNs (4.1) has a unique weighted pseudo almost periodic solution x(t)PAPμ(R,R2), and every solutions of (4.1) is exponentially convergent to x(t) as t+. Here, the exponential convergence rate σ0.01. Simulations in Figure 1 reflect that the theoretical convergence is in sympathy with the numerically observed behaviors.

    Figure 1.  Numerical solutions x(t) to system (3.1) with initial values: (φ1(s), φ2(s))=(2,2), (3,2), (3,2), t0=1.

    As far as we know, the weighted pseudo almost periodic dynamics of cellular neural networks with D operator and multi-proportional delays has never been studied in the previous literature [29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52]. It is easy to see that all results in [16,17,18,19,20,21,22,23,24,25,26,27,28] cannot be directly applied to show the case that all solutions of (4.1) converge globally to the weighted pseudo almost periodic solution. In particular, all parameters in system (4.1) are chosen by applying Matlab software. It should be mentioned that the nonlinear activation function fi(x)=120arctanx has been usually used as the sigmoid functions to agree with the experimental data of signal transmission in the real cellular networks networks.

    In this paper, we investigate the global dynamic behaviors on a class of neutral type CNNs with D operator and multi-proportional delays. Some new criteria have been gained to guarantee that the existence and exponential stability of weighted pseudo almost periodic solutions for the addressed system by combining the fixed point theorem and some differential inequality techniques. The obtained results are new and complement some corresponding ones of the existing literature. It should be mentioned that the technical assumptions can be easily checked by simple algebra methods and convenient for application in practice. In addition, this method affords a possible approach to study the weighted pseudo dynamics of other cellular neural networks with D operator and delays. In the future, we will make this further research.

    The author would like to express his sincere appreciation to the editor and reviewers for their helpful comments in improving the presentation and quality of the paper. This work was supported by the Postgraduate Scientific Research Innovation Project of Hunan Province (No. CX20200892) and "Double first class" construction project of CSUST in 2020 ESI construction discipline, Grant No. 23/03.

    We confirm that we have no conflict of interest.



    Conflict of interest



    All authors declare no conflict of interest.

    Authors' contribution



    Conceptualization—Białoń Natalia; Draft manuscript preparation—Białoń Natalia, Dariusz Górka, Mikołaj Górka; Data collection—Białoń Natalia; Visualization—Mikołaj Górka; Review and editing—Dariusz Górka; All authors reviewed and approved the final version of the manuscript.

    [1] Żakowicz J, Bramorska A, Zarzycka W, et al. (2020) Wpływ mikrobioty jelitowej na mózg, funkcje poznawcze i emocje. Kosmos problemy nauk biologicznych 69: 45-58. https://doi.org/10.36921/kos.2020_2634
    [2] Dinan TG, Stanton C, Cryan JF (2013) Psychobiotics: a novel class of psychotropic. Biol Psychiatry 74: 720-726. https://doi.org/10.1016/j.biopsych.2013.05.001
    [3] Góralczyk-Bińkowska A, Szmajda-Krygier D, Kozłowska E (2022) The Microbiota-Gut-Brain Axis in Psychiatric Disorders. Int J Mol Sci 23: 11245. https://doi.org/10.3390/ijms231911245
    [4] Dinan TG, Cryan JF (2017) Brain-Gut-Microbiota Axis and Mental Health. Psychosom Med 79: 920-926. https://doi.org/10.1097/PSY.0000000000000519
    [5] Nowicka D, Chilicka K, Dzieńdziora-Urbińska I (2022) Host-Microbe Interaction on the Skin and Its Role in the Pathogenesis and Treatment of Atopic Dermatitis. Pathogens 11: 71. https://doi.org/10.3390/pathogens11010071
    [6] Daniel H (2020) Diet and the gut microbiome: From hype to hypothesis. Br J Nutr 124: 521-530. https://doi.org/10.1017/S0007114520001142
    [7] Enaud R, Vandenborght LE, Coron N, et al. (2018) The Mycobiome: A Neglected Component in the Microbiota-Gut-Brain Axis. Microorganisms 6: 22. https://doi.org/10.3390/microorganisms6010022
    [8] Sureda A, Daglia M, Argüelles Castilla S, et al. (2020) Oral microbiota and Alzheimer's disease: Do all roads lead to Rome?. Pharmacol Res 151: 104582. https://doi.org/10.1016/j.phrs.2019.104582
    [9] Gałecka M, Basińska A, Bartnicka A (2018) Znaczenie mikrobioty jelitowej w kształtowaniu zdrowia człowieka – implikacje w praktyce lekarza rodzinnego. Journals Via Medica 12: 50-59.
    [10] Bartnicka A, Gałęcka M, Mazela J (2016) Wpływ czynników prenatalnych i postnatalnych na mikrobiotę jelitową noworodków. Stand Med Pediatr 13: 112-116.
    [11] Dominguez-Bello MG, Costello EK, Contreras M, et al. (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 107: 11971-11975. https://doi.org/10.1073/pnas.1002601107
    [12] Cukrowska B (2016) Znaczenie programowania mikrobiotycznego w rozwoju przewlekłych chorób infekcyjnych. Stand Med Pediatr 13: 1019-1028.
    [13] Gałęcka M, Bartnicka A, Szewc M, et al. (2016) Kształtowanie się mikrobioty jelitowej u niemowląt warunkiem zachowania zdrowia. Standardy medyczne pediatria 13: 359-367.
    [14] Lee YK, Menezes JS, Umesaki Y, et al. (2011) Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A : 4615-4622. https://doi.org/10.1073/pnas.1000082107
    [15] Tlaskalová-Hogenová H, Stěpánková R, Kozáková H, et al. (2011) The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 8: 110-120. https://doi.org/10.1038/cmi.2010.67
    [16] Martin CR, Osadchiy V, Kalani A, et al. (2018) The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol 6: 133-148. https://doi.org/10.1016/j.jcmgh.2018.04.003
    [17] Brown K, DeCoffe D, Molcan E, et al. (2012) Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 4: 1095-1119. https://doi.org/10.3390/nu4081095
    [18] González Olmo BM, Butler MJ, Barrientos RM (2021) Evolution of the Human Diet and Its Impact on Gut Microbiota, Immune Responses, and Brain Health. Nutrients 13: 196. https://doi.org/10.3390/nu13010196
    [19] Foster JA, Rinaman L, Cryan JF (2017) Stress & the gut-brain axis: Regulation by the microbiome. Neurobiol Stress 7: 124-136. https://doi.org/10.1016/j.ynstr.2017.03.001
    [20] Tannock GW, Savage DC (1974) Influences of dietary and environmental stress on microbial populations in the murine gastrointestinal tract. Infect Immun 9: 591-598. https://doi.org/10.1128/iai.9.3.591-598.1974
    [21] Bailey MT, Dowd SE, Galley JD, et al. (2011) Exposure to social stressors alters the structure of the intestinal microbiota. Brain Behav Immun 25: 397-407. https://doi.org/10.1016/j.bbi.2010.10.023
    [22] Cryan JF, O'Riordan KJ, Cowan CSM, et al. (2019) The Microbiota-Gut-Brain Axis. Physiol Rev 99: 1877-2013. https://doi.org/10.1152/physrev.00018.2018
    [23] Berthoud HR, Neuhuber WL (2000) Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 85: 1-17. https://doi.org/10.1016/S1566-0702(00)00215-0
    [24] AGOSTONI E, CHINNOCK JE, DE DALY MB, et al. (1957) Functional and histological studies of the vagus nerve and its branches to the heart, lungs and abdominal viscera in the cat. J Physiol 135: 182-205. https://doi.org/10.1113/jphysiol.1957.sp005703
    [25] Prechtl JC, Powley TL (1990) B-Afferents: A fundamental division of the nervous system mediating homeostasis?. Behav Brain Sci 13: 289-300. https://doi.org/10.1017/S0140525X00078729
    [26] Suarez AN, Noble EE, Kanoski SE (2019) Regulation of memory function by feeding-relevant biological systems: Following the bread-crumbs to the hippocampus. Front Mol Neurosci 12: 1-21. https://doi.org/10.3389/fnmol.2019.00101
    [27] Wang Y, Zhan G, Cai Z, et al. (2021) Vagus nerve stimulation in brain diseases: Therapeutic applications and biological mechanisms. Neurosci Biobehav Rev 127: 37-53. https://doi.org/10.1016/j.neubiorev.2021.04.018
    [28] Jin Z, Dong J, Wang Y, et al. (2023) Exploring the potential of vagus nerve stimulation in treating brain diseases: a review of immunologic benefits and neuroprotective efficacy. Eur J Med Res 28: 444. https://doi.org/10.1186/s40001-023-01439-2
    [29] Bonaz B, Sinniger V, Pellissier S (2016) Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. J Physiol 594: 5781-5790. https://doi.org/10.1113/JP271539
    [30] Meregnani J, Clarençon D, Vivier M, et al. (2011) Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci 160: 82-89. https://doi.org/10.1016/j.autneu.2010.10.007
    [31] Merrill CA, Jonsson MA, Minthon L, et al. (2006) Vagus nerve stimulation in patients with Alzheimer's disease: additional follow-up results of a pilot study through 1 year. J Clin Psychiatry 67: 1171-1178. https://doi.org/10.4088/JCP.v67n0801
    [32] Dawson J, Engineer ND, Prudente CN, et al. (2020) Vagus nerve stimulation paired with upper-limb rehabilitation after stroke: one-year follow-up. Neurorehabil Neural Repair 34: 609-615. https://doi.org/10.1177/1545968320924361
    [33] Mondal B, Choudhury S, Simon B, et al. (2019) Noninvasive vagus nerve stimulation improves gait and reduces freezing of gait in Parkinson's disease. Mov Disord 34: 917-918. https://doi.org/10.1002/mds.27662
    [34] Hays SA (2016) Enhancing rehabilitative therapies with vagus nerve stimulation. Neurotherapeutics 13: 382-394. https://doi.org/10.1007/s13311-015-0417-z
    [35] Kaelberer MM, Buchanan K, Klein ME, et al. (2018) A gut-brain neural circuit for nutrient sensory transduction. Science 361. https://doi.org/10.1126/science.aat5236
    [36] Dinan TG, Stilling RM, Stanton C, et al. (2015) Collective unconscious: How gut microbes shape human behavior. J Psychiatric Res 63: 1-9. https://doi.org/10.1016/j.jpsychires.2015.02.021
    [37] Dantzer R (2009) Cytokine, sickness behavior, and depression. Immunol. Allergy Clin North Am 29: 247-264. https://doi.org/10.1016/j.iac.2009.02.002
    [38] Rogers GB, Keating DJ, Young RL, et al. (2016) From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry 21: 738-748. https://doi.org/10.1038/mp.2016.50
    [39] Sarkar A, Lehto SM, Harty S, et al. (2016) Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends Neurosci 39: 763-781. https://doi.org/10.1016/j.tins.2016.09.002
    [40] Martin-Gallausiaux C, Marinelli L, Blottière HM, et al. (2020) SCFA: mechanisms and functional importance in the gut. P Nutr Soc 80: 37-49. https://doi.org/10.1017/S0029665120006916
    [41] Fusco W, Lorenzo MB, Cintoni M, et al. (2011) Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota. Nutrients 15: 2211. https://doi.org/10.3390/nu15092211
    [42] Atarashi K, Tanoue T, Shima T, et al. (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337-341. https://doi.org/10.1126/science.1198469
    [43] Smith PM, Howitt MR, Panikov N, et al. (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341: 569-573. https://doi.org/10.1126/science.1241165
    [44] Dupraz L, Magniez A, Rolhion N, et al. (2021) Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal γδ T cells. Cell Rep 36: 109332. https://doi.org/10.1016/j.celrep.2021.109332
    [45] Biagioli M, Carino A (2019) Signaling from intestine to the host: how bile acids regulate intestinal and liver immunity. Handb Exp Pharmacol 256: 95-108. https://doi.org/10.1007/164_2019_225
    [46] Bairamian D, Sha S, Rolhion N, et al. (2022) Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer's disease. Mol Neurodegener 17: 19. https://doi.org/10.1186/s13024-022-00522-2
    [47] Hoogland ICM, Houbolt C, Westerloo DJ, et al. (2015) Systemic inflammation and microglial activation: systemic review of animal experiments. J Neuroinflamm 12: 114. https://doi.org/10.1186/s12974-015-0332-6
    [48] Gareau MG, Wine E, Rodrigues DM, et al. (2011) Bacterial infection causes stress-induced memory dysfunction in mice. Gut 60: 307-317. https://doi.org/10.1136/gut.2009.202515
    [49] Sudo N, Chida Y, Aiba Y, et al. (2004) Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 558: 263-275. https://doi.org/10.1113/jphysiol.2004.063388
    [50] Silva YP, Bernardi A, Frozza RL (2020) The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne) 11: 25. https://doi.org/10.3389/fendo.2020.00025
    [51] Mao YK, Kasper DL, Wang B, et al. (2013) Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons. Nat Comm 4: 1465. https://doi.org/10.1038/ncomms2478
    [52] De Vadder F, Grasset E, Holm LM, et al. (2018) Gut microbiota regulates maturation of the adult enteric nervous system via enteric serotonin networks. Proc Natl Acad Sci USA 115: 6458-6463. https://doi.org/10.1073/pnas.1720017115
    [53] Nandwana V, Nandwana NK, Das Y, et al. (2022) The Role of Microbiome in Brain Development and Neurodegenerative Diseases. Molecules 27: 3402. https://doi.org/10.3390/molecules27113402
    [54] Wojtania MA, Majewska EM, Duda W (2024) Importance of gut microbiome in Alzheimer's disease. Med Srod 27: 60-65. https://doi.org/10.26444/ms/188315
    [55] Uysal G, Ozturk M (2020) Hippocampal atrophy based Alzheimer's disease diagnosis via machine learning methods. J Neurosci Methods 337: 108669. https://doi.org/10.1016/j.jneumeth.2020.108669
    [56] Alzheimer's Association.Alzheimer's disease facts and figures. Alzheimers Dement (2016) 12: 459-509. https://doi.org/10.1016/j.jalz.2016.03.001
    [57] Winblad B, Amouyel P, Andrieu S, et al. (2016) Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol 15: 455-532. https://doi.org/10.1016/S1474-4422(16)00062-4
    [58] Liu P, Wu L, Peng G, et al. (2019) Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav Immun 80: 633-643. https://doi.org/10.1016/j.bbi.2019.05.008
    [59] Roubaud-Baudron C, Krolak-Salmon P, Quadrio I, et al. (2012) Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results. Neurobiol Aging 33: 1009.e11-9. https://doi.org/10.1016/j.neurobiolaging.2011.10.021
    [60] Chen SG, Stribinskis V, Rane MJ, et al. (2016) Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans. Sci Rep 6: 34477. https://doi.org/10.1038/srep34477
    [61] Pistollato F, Sumalla Cano S, Elio I, et al. (2016) Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr Rev 74: 624-34. https://doi.org/10.1093/nutrit/nuw023
    [62] Jang SE, Lim SM, Jeong JJ, et al. (2018) Gastrointestinal inflammation by gut microbiota disturbance induces memory impairment in mice. Mucosal Immunol 11: 369-379. https://doi.org/10.1038/mi.2017.49
    [63] Zhao Y, Jaber V, Lukiw WJ (2017) Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus. Front Cell Infect Microbiol 7: 318. https://doi.org/10.3389/fcimb.2017.00318
    [64] Sun MF, Shen YQ (2018) Dysbiosis of gut microbiota and microbial metabolites in Parkinson's disease. Ageing Res Rev 45: 53-61. https://doi.org/10.1016/j.arr.2018.04.004
    [65] Li B, He Y, Ma J, et al. (2019) Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota. Alzheimers Dement 15: 1357-1366. https://doi.org/10.1016/j.jalz.2019.07.002
    [66] Perez-Pardo P, Kliest T, Dodiya HB, et al. (2017) The gut-brain axis in Parkinson's disease: Possibilities for foodbased therapies. Eur J Pharmacol 817: 86-95. https://doi.org/10.1016/j.ejphar.2017.05.042
    [67] Kim S, Kwon SH, Kam TI, et al. (2019) Transneuronal propagation ff pathologic α-synuclein from the gut to the brain models Parkinson's disease. Neuron 103: 627-641. https://doi.org/10.1016/j.neuron.2019.05.035
    [68] Sampson TR, Debelius JW, Thron T, et al. (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 167: 1469-1480. https://doi.org/10.1016/j.cell.2016.11.018
    [69] Sun MF, Shen YQ (2018) Dysbiosis of gut microbiota and microbial metabolites in Parkinson's disease. Ageing Res Rev 45: 53-61. https://doi.org/10.1016/j.arr.2018.04.004
    [70] Marizzoni M, Provasi S, Cattaneo A, et al. (2017) Microbiota and neurodegenerative diseases. Curr Opin Neurol 30: 630-638. https://doi.org/10.1097/WCO.0000000000000496
    [71] Perez-Pardo P, Kliest T, Dodiya HB, et al. (2017) The gut-brain axis in Parkinson's disease: Possibilities for foodbased therapies. Eur J Pharmacol 817: 86-95. https://doi.org/10.1016/j.ejphar.2017.05.042
    [72] van den Hoogen WJ, Laman JD, 't Hart BA (2017) Modulation of multiple sclerosis and its animal model experimental autoimmune encephalomyelitis by food and gut microbiota. Front Immunol 8: 1081. https://doi.org/10.3389/fimmu.2017.01081
    [73] Mowry EM, Glenn JD (2018) The dynamics of the gut microbiome in multiple sclerosis in relation to disease. Neurol Clin 36: 185-196. https://doi.org/10.1016/j.ncl.2017.08.008
    [74] Chu F, Shi M, Lang Y, et al. (2018) Gut microbiota in multiple sclerosis and experimental autoimmune encephalomyelitis: current applications and future perspectives. Mediators Inflamm 2018: 8168717. https://doi.org/10.1155/2018/8168717
    [75] Jiang HY, Zhang X, Yu ZH, et al. (2018) Altered gut microbiota profile in patients with generalized anxiety disorder. J Psychiatr Res 104: 130-136. https://doi.org/10.1016/j.jpsychires.2018.07.007
    [76] Rogers GB, Keating DJ, Young RL, et al. (2016) From gut dysbiosis to altered brain function and mental illness: Mechanisms and pathways. Mol Psychiatr 21: 738-748. https://doi.org/10.1038/mp.2016.50
    [77] Tognini P (2017) Gut microbiota: A potential regulator of neurodevelopment. Front Cell Neurosci 11: 25. https://doi.org/10.3389/fncel.2017.00025
    [78] Valles-Colomer M, Falony G, Darzi Y, et al. (2019) The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol 4: 623-632. https://doi.org/10.1038/s41564-018-0337-x
    [79] Dash S, Syed YA, Khan MR (2022) Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders. Front Cell Dev Biol 10: 880544. https://doi.org/10.3389/fcell.2022.880544
    [80] Frémont M, Coomans D, Massart S, et al. (2013) High-throughput 16S rRNA Gene Sequencing Reveals Alterations of Intestinal Microbiota in Myalgic Encephalomyelitis/chronic Fatigue Syndrome Patients. Anaerobe 22. https://doi.org/10.1016/j.anaerobe.2013.06.002
    [81] Skonieczna-Żydecka K, Łoniewski I, Maciejewska D, et al. (2017) Mikrobiota jelitowa i składniki pokarmowe jako determinanty funkcji układu nerwowego. Część I. Mikrobiota przewodu pokarmowego. Aktual Neurol 17: 181-188. https://doi.org/10.15557/AN.2017.0020
    [82] Strati F, Cavalieri D, Albanese D, et al. (2017) New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome 5: 24. https://doi.org/10.1186/s40168-017-0242-1
    [83] Hashimoto K (2023) Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions. Mol Psychiatr 28: 3625-3637. https://doi.org/10.1038/s41380-023-02287-6
    [84] Hou K, Wu ZX, Chen XY, et al. (2022) Microbiota in health and disease. Signal Transduct Target Ther 7: 135. https://doi.org/10.1038/s41392-022-00974-4
    [85] Aggarwal N, Kitano S, Puah GRY, et al. (2023) Microbiome and human health: current understanding, engineering, and enabling technologies. Chem Rev 123: 31-72. https://doi.org/10.1021/acs.chemrev.2c00431
    [86] Martínez M, Postolache TT, García-Bueno B, et al. (2022) The role of the oral microbiota related to periodontal diseases in anxiety, mood and trauma- and stress-related disorders. Front Psych 12: 814177. https://doi.org/10.3389/fpsyt.2021.814177
    [87] Kisely S, Sawyer E, Siskind D, et al. (2016) The oral health of people with anxiety and depressive disorders-a systematic review and meta-analysis. J Affect Disord 200: 119-32. https://doi.org/10.1016/j.jad.2016.04.040
    [88] Coelho JMF, Miranda SS, da Cruz SS, et al. (2020) Common mental disorder is associated with periodontitis. J Periodontal Res 55: 221-8. https://doi.org/10.1111/jre.12705
    [89] Dominy SS, Lynch C, Ermini F, et al. (2019) Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv 5: eaau3333. https://doi.org/10.1126/sciadv.aau3333
    [90] Pisani F, Pisani V, Arcangeli F, et al. (2023) Treponema denticola Has the Potential to Cause Neurodegeneration in the Midbrain via the Periodontal Route of Infection-Narrative Review. Int J Environ Res Public Health 20: 6049. https://doi.org/10.3390/ijerph20116049
    [91] Emery DC, Shoemark DK, Batstone TE, et al. (2017) 16S rRNA next generation sequencing analysis shows bacteria in Alzheimer's post-mortem brain. Front Aging Neurosci 9: 195. https://doi.org/10.3389/fnagi.2017.00195
    [92] Siddiqui H, Rribe ERK, Singhrao SK, et al. (2019) High throughput sequencing detects gingivitis and periodontal oral bacteria in Alzheimer's disease autopsy brains. Neuro Res 1: 3. https://doi.org/10.35702/nrj.10003
    [93] Weber C, Dilthey A, Finzer P (2023) The role of microbiome–host interactions in the development of Alzheimer's disease. Front Cell Infect Microbiol 13: 1151021. https://doi.org/10.3389/fcimb.2023.1151021
    [94] Emery DC, Davies M, Cerajewska TL, et al. (2022) High resolution 16S rRNA gene Next Generation Sequencing study of brain areas associated with Alzheimer's and Parkinson's disease. Front Aging Neurosci 14: 1026260. https://doi.org/10.3389/fnagi.2022.1026260
    [95] Berthouzoz E, Lazarevic V, Zekeridou A, et al. (2023) Oral and intestinal dysbiosis in Parkinson's disease. Rev Neurol (Paris) 179: 937-946. https://doi.org/10.1016/j.neurol.2022.12.010
    [96] Jo S, Kang W, Hwang YS, et al. (2022) Oral and gut dysbiosis leads to functional alterations in Parkinson's disease. NPJ Parkinsons Dis 8: 87. https://doi.org/10.1038/s41531-022-00351-6
    [97] Li Z, Lu G, Luo E, et al. (2022) Oral, nasal, and gut microbiota in Parkinson's disease. Neuroscience 480: 65-78. https://doi.org/10.1016/j.neuroscience.2021.10.011
    [98] Goswami A, Wendt FR, Pathak GA, et al. (2021) Role of microbes in the pathogenesis of neuropsychiatric disorders. Front Neuroendocrinol 21: 100917. https://doi.org/10.1016/j.yfrne.2021.100917
    [99] Ferraretto A, Donetti E, García-Mena J, et al. (2023) Editorial: The gut-skin-brain axis in human health and disease. Front Nutr 10: 1155614. https://doi.org/10.3389/fnut.2023.1155614
    [100] Hermes BM, Rademacher F, Chung C, et al. (2022) Skin microbiota analysis in patients with anorexia nervosa and healthy-weight controls reveals microbial indicators of healthy weight and associations with the antimicrobial peptide psoriasin. Sci Rep 12: 15515. https://doi.org/10.1038/s41598-022-19676-6
    [101] Arikan M, Yildiz Z, Kahraman Demir T, et al. (2022) Axillary microbiota is associated with cognitive impairment in Parkinson's disease patients. Microbiol Spectr 10: e0235821. https://doi.org/10.1128/spectrum.02358-21
    [102] Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323: 1945-60. https://doi.org/10.1001/jama.2020.4006
    [103] Griffiths CEM, Armstrong AW, Gudjonsson JE, et al. (2021) Psoriasis. Lancet 397: 1301-15. https://doi.org/10.1016/S0140-6736(20)32549-6
    [104] Hadian Y, Fregoso D, Nguyen C, et al. (2020) Microbiome-skin-brain axis: A novel paradigm for cutaneous wounds. Wound Repair Regen 28: 282-92. https://doi.org/10.1111/wrr.12800
    [105] Woo YR, Han YJ, Kim HS, et al. (2020) Updates on the risk of neuropsychiatric and gastrointestinal comorbidities in rosacea and its possible relationship with the gut-brain-skin axis. Int J Mol Sci 21: 8427. https://doi.org/10.3390/ijms21228427
    [106] Chen G, Chen ZM, Fan XY, et al. (2021) Gut-brain-skin axis in psoriasis: a review. Dermatol Ther (Heidelb) 11: 25-38. https://doi.org/10.1007/s13555-020-00466-9
    [107] Wang X, Li Y, Wu L, et al. (2021) Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression. Biomed Pharmacother 137: 111065. https://doi.org/10.1016/j.biopha.2020.111065
    [108] Shinno-Hashimoto H, Hashimoto Y, Wei Y, et al. (2021) Abnormal composition of microbiota in the gut and skin of imiquimod-treated mice. Sci Rep 11: 112665. https://doi.org/10.1038/s41598-021-90480-4
    [109] Kumpitsch C, Koskinen K, Schöpf V, et al. (2019) The microbiome of the upper respiratory tract in health and disease. BMC Biol 17: 87. https://doi.org/10.1186/s12915-019-0703-z
    [110] Tai J, Han MS, Kwak J, et al. (2021) Association between microbiota and nasal mucosal diseases in terms of immunity. Int J Mol Sci 22: 4744. https://doi.org/10.3390/ijms22094744
    [111] Thangaleela S, Sivamaruthi BS, Kesika P, et al. (2022) Nasal microbiota, olfactory health, neurological disorders and aging—a review. Microorganisms 10: 1405. https://doi.org/10.3390/microorganisms10071405
    [112] Xie J, Tian S, Liu J, et al. (2022) Dual role of the nasal microbiota in neurological diseases-An unignorable risk factor or a potential therapy carrier. Pharmacol Res 179: 106189. https://doi.org/10.1016/j.phrs.2022.106189
    [113] Sarkar A, Lehto SM, Harty S, et al. (2016) Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends Neurosci 39: 763-781. https://doi.org/10.1016/j.tins.2016.09.002
    [114] Snigdha S, Ha K, Tsai P, et al. (2022) Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan. Pharmacol Ther 231: 107978. https://doi.org/10.1016/j.pharmthera.2021.107978
    [115] Chung Y, Jin H, Cui Y (2014) Fermented milk of Lactobacillus helveticus IDCC3801 improves cognitive functioning during cognitive fatigue tests in healthy older adults. J Funct Foods 10: 465-474. https://doi.org/10.1016/j.jff.2014.07.007
    [116] Allen AP, Hutch W, Borre YE, et al. (2016) Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Translat. Psychiatry 6: 939-939. https://doi.org/10.1038/tp.2016.191
    [117] Moloney GM, Long-Smith CM, Murphy A (2020) Improvements in sleep indices during exam stress due to consumption of a Bifidobacterium longum. Brain Behav Immun Health 10: 100174. https://doi.org/10.1016/j.bbih.2020.100174
    [118] Zhao M, Ren Z, Zhao A, et al. (2024) Gut bacteria-driven homovanillic acid alleviates depression by modulating synaptic integrity. Cell Metab 36: 1000-1012.e6. https://doi.org/10.1016/j.cmet.2024.03.010
    [119] Chong HX, Yusoff NAA, Hor YY, et al. (2019) Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: a randomised, double-blind, placebo-cont controlled study. Benef Microbes 10: 355-373. https://doi.org/10.3920/BM2018.0135
    [120] Kelly JR, Allen AP, Temko A, et al. (2017) Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behav Immun 61: 50-59. https://doi.org/10.1016/j.bbi.2016.11.018
    [121] Kochalska K, Oakden W, Słowik T, et al. (2020) Dietary supplementation with Lactobacillus rhamnosus JB-1 restores brain neurochemical balance and mitigates the progression of mood disorder in a rat model of chronic unpredictable mild stress. Nutr Res 82: 44-57. https://doi.org/10.1016/j.nutres.2020.06.019
    [122] Jarosz ŁS, Socała K, Michalak K, et al. (2024) The effect of psychoactive bacteria, Bifidobacterium longum Rosell®-175 and Lactobacillus rhamnosus JB-1, on brain proteome profiles in mice. Psychopharmacology (Berl) 241: 925-945. https://doi.org/10.1007/s00213-023-06519-z
    [123] Yunes RA, Poluektova EU, Vasileva EV, et al. (2020) A Multi-strain Potential Probiotic Formulation of GABA-Producing Lactobacillus plantarum 90sk and Bifidobacterium adolescentis 150 with Antidepressant Effects. Probiotics Antimicrob. Proteins 12: 973-979. https://doi.org/10.1007/s12602-019-09601-1
    [124] De Oliveira FL, Salgaço MK, de Oliveira MT, et al. (2023) Exploring the Potential of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 as Promising Psychobiotics Using SHIME. Nutrients 15: 1521. https://doi.org/10.3390/nu15061521
    [125] Asaoka D, Xiao J, Takeda T, et al. (2022) Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial. J Alzheimers Dis 88: 75-95. https://doi.org/10.3233/JAD-220148
  • Reader Comments
  • © 2024 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(2482) PDF downloads(142) Cited by(1)

Figures and Tables

Figures(1)  /  Tables(1)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog